O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
-4.98%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.79B
AUM Growth
+$7.79B
(-11%)
Cap. Flow
-$283M
Cap. Flow
% of AUM
-3.63%
Top 10 Holdings %
Top 10 Hldgs %
37.29%
Holding
146
New
9
Increased
32
Reduced
26
Closed
16
Top Buys
| 1 |
Elevance Health
ELV
|
$147M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$91.8M |
| 3 |
AET
Aetna Inc
AET
|
$85.5M |
| 4 |
Humana
HUM
|
$84.2M |
| 5 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$74.7M |
Top Sells
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$146M |
| 2 |
Molina Healthcare
MOH
|
$116M |
| 3 |
ESRX
Express Scripts Holding Company
ESRX
|
$102M |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$89.8M |
| 5 |
AbbVie
ABBV
|
$81.7M |
Sector Composition
| 1 | Healthcare | 94.69% |
| 2 | Financials | 1.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
GWPH
51
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $44.3M | 0.56% | 396,600 +360,400 | +996% | +$40.3M |
|
52
Cooper Companies
COO
$13.4B
| $43.8M | 0.56% | 250,100 | – | – |
|
53
Jazz Pharmaceuticals
JAZZ
$7.75B
| $40.5M | 0.52% | 371,400 +124,500 | +50% | +$13.6M |
|
54
Stryker
SYK
$150B
| $37.9M | 0.48% | 316,300 +104,300 | +49% | +$12.5M |
|
55
Intellia Therapeutics
NTLA
$1.22B
| $34.9M | 0.44% | 2,662,180 | – | – |
|
56
Cartesian Therapeutics
RNAC
$261M
| $31.6M | 0.4% | 1,842,797 | – | – |
|
|
OTIC
57
DELISTED
Otonomy, Inc.
OTIC
| $29.4M | 0.37% | 1,850,094 | – | – |
|
|
VRAY
58
DELISTED
ViewRay, Inc.
VRAY
| $28.6M | 0.36% | 9,127,990 | – | – |
|
|
ONC
59
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $27.4M | 0.35% | +903,700 | New | +$27.4M |
|
|
60
Molina Healthcare
MOH
$9.8B
| $26.9M | 0.34% | 496,200 -2,138,500 | -81% | -$116M |
|
61
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $23.9M | 0.3% | 850,100 +178,500 | +27% | +$5.02M |
|
62
Iovance Biotherapeutics
IOVA
$807M
| $23.5M | 0.3% | 3,382,900 | – | – |
|
|
DMTX
63
DELISTED
Dimension Therapeutics, Inc
DMTX
| $23.5M | 0.3% | 5,397,698 | – | – |
|
64
Illumina
ILMN
$15.8B
| $23.3M | 0.3% | 182,200 -313,300 | -63% | -$40.1M |
|
65
Teva Pharmaceuticals
TEVA
$21.1B
| $22.3M | 0.28% | 614,500 -1,216,900 | -66% | -$44.1M |
|
66
Xencor
XNCR
$580M
| $22.1M | 0.28% | 840,237 +95,715 | +13% | +$2.52M |
|
|
LUMO
67
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $20.5M | 0.26% | 1,991,700 +53,400 | +3% | +$549K |
|
68
eHealth
EHTH
$118M
| $19.4M | 0.25% | 1,820,000 +5,000 | +0.3% | +$53.3K |
|
69
Galapagos
GLPG
$2.07B
| $18.2M | 0.23% | 283,500 -174,400 | -38% | -$11.2M |
|
|
BLUE
70
DELISTED
bluebird bio
BLUE
| $17.5M | 0.22% | 283,800 -902,000 | -76% | -$55.7M |
|
71
Assembly Biosciences
ASMB
$190M
| $17M | 0.22% | 1,397,100 | – | – |
|
|
SVA
72
DELISTED
Sinovac Biotech, Ltd
SVA
| $15.7M | 0.2% | 2,667,500 | – | – |
|
73
Natera
NTRA
$23.1B
| $14.9M | 0.19% | 1,276,190 | – | – |
|
|
IMMU
74
DELISTED
Immunomedics Inc
IMMU
| $14M | 0.18% | 3,802,000 | – | – |
|
|
BCR
75
DELISTED
CR Bard Inc.
BCR
| $13M | 0.17% | 58,000 | – | – |
|